Lv31
260 积分 2023-12-02 加入
Immune checkpoint inhibitor resistance in hepatocellular carcinoma
1小时前
待确认
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
8小时前
已完结
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
25天前
已完结
Predictive biomarkers for systemic therapy of hepatocellular carcinoma
25天前
已完结
1012P First-in-human study of ABSK-011, a novel, highly selective fibroblast growth factor receptor (FGFR) 4 inhibitor for treating advanced hepatocellular carcinoma (HCC) with FGF19 overexpression
1个月前
已完结
Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)
1个月前
已关闭
Abstract CT106: Ph I/II study of FGF401 in adult pts with HCC or solid tumors characterized by FGFR4/KLB expression
1个月前
已关闭
Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)
1个月前
已关闭
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
1个月前
已完结
Predictive biomarkers for systemic therapy of hepatocellular carcinoma
1个月前
已完结
皖公网安备34019202002308
